Distinguished in Multiple Sclerosis (MS)

Marc G. Pawlitzki

Heine, NW, DE 
Distinguished in Multiple Sclerosis (MS)
Heine, NW, DE 
OverviewLocationsClinical Research

Overview

Marc Pawlitzki practices in Heine, Germany. Mr. Pawlitzki is rated as a Distinguished expert by MediFind in the treatment of Multiple Sclerosis (MS). His top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Myasthenia Gravis, Optic Neuritis, and Thymectomy.

His clinical research consists of co-authoring 119 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 48 articles in the study of Multiple Sclerosis (MS).

Gender
Male

Locations

Heine, NW, Germany
Other Locations
Duesseldorf, NW, Germany
Magdeburg, ST, Germany
Muenster, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Phase II Trial of Vaccination with Lysate-loaded, Mature Dendritic Cells Integrated Into Standard Radiochemotherapy in Newly Diagnosed Glioblastoma
Phase II Trial of Vaccination with Lysate-loaded, Mature Dendritic Cells Integrated Into Standard Radiochemotherapy in Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: December 02, 2024
Intervention Type: Drug, Biological
Study Drugs: Autologous, Tumor Lysate-Loaded, Mature Dendritic Cells (DC), Standard Therapy
Study Phase: Phase 2

119 Total Publications

Therapeutic approaches in adults with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A review of current evidence.
Therapeutic approaches in adults with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A review of current evidence.
Journal: Autoimmunity reviews
Published: October 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pawlitzki's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 34 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile